Records containing: Opioid Use Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-08-01An Open-Label Multicenter Study Assessing the Long-Term Safety of a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injection Depot of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2019-05-21Chronic Intranasal Oxytocin as an Adjunct to Methadone Maintenance Treatment in Patients With Co-occuring Opioid Use Disorder and Cocaine Use: A 2-week Pilot Study
-
CLINICAL_TRIALS study record update · 2019-03-04A Systematic Medical Approach to Reward Transformation (SMART) for Brain Health in Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2019-02-26Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study
-
CLINICAL_TRIALS study record update · 2019-02-12A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety, Tolerability, and Efficacy of Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-01-09A Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL®
-
CLINICAL_TRIALS study record update · 2018-12-12MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)
-
CLINICAL_TRIALS study record update · 2018-11-02An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2018-10-31Medication-Assisted Treatment for Youth With Substance Use Disorders
-
CLINICAL_TRIALS study record update · 2018-04-24A Multiple-Dose Study of Blockade of Subjective Opioid Effects, Plasma Levels, and Safety of Subcutaneous Injections of Depot Buprenorphine (RBP-6000) in Subjects With Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2018-04-23Buprenorphine Tx:A Safe Alternative for Opioid Dependent Pain Patients
-
CLINICAL_TRIALS study record update · 2018-03-29An Open-Label, Long-Term Safety and Tolerability Study of Depot Buprenorphine (RBP-6000) in Treatment-Seeking Subjects With Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2018-01-19CTN-0051: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
-
CLINICAL_TRIALS study record update · 2017-10-17Improving Women's Sexual Health While in Drug Addiction Treatment
-
CLINICAL_TRIALS study record update · 2017-04-25The Expanded HIV Care in Opioid Substitution Treatment (EHOST) Stepped-wedge, Cluster-randomized Trial
-
CLINICAL_TRIALS study record update · 2017-01-31A Single-Center, Randomized, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine (RBP-6000) Using Poly (DL-lactide-co-glycolide) Polymer of Two Different Molecular Weights (Low and High Molecular Weights as Test Treatments) in Comparison to Intermediate Molecular Weight (Reference Treatment) in Treatment-Seeking Subjects With Opioid Use Disorder
-
CLINICAL_TRIALS study record update · 2017-01-16Project RESPECT-Plus: Recovery, Empowerment, Social Services, Prenatal Care, Education and Community Treatment-Plus
-
CLINICAL_TRIALS study record update · 2016-12-26A Multicenter, Open-Label, Single Ascending-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Depot Buprenorphine (RBP-6000) in Opioid-Dependent Subjects
-
CLINICAL_TRIALS study record update · 2016-05-09A Single-Dose, Open-Label Study of Depot Buprenorphine (RBP-6000) in Opioid-Dependent Individuals